PubRank

Jianxiang Wang

Author PubWeight™ 57.54‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Dasatinib or imatinib in newly diagnosed chronic-phase chronic myeloid leukemia: 2-year follow-up from a randomized phase 3 trial (DASISION). Blood 2011 3.71
2 Chronic myeloid leukemia in Asia. Int J Hematol 2008 1.86
3 Risk of MDM2 SNP309 alone or in combination with the p53 codon 72 polymorphism in acute myeloid leukemia. Leuk Res 2009 1.64
4 Aberrant expression of TSC2 gene in the newly diagnosed acute leukemia. Leuk Res 2009 1.52
5 siRNA-mediated down-regulation of iASPP promotes apoptosis induced by etoposide and daunorubicin in leukemia cells expressing wild-type p53. Leuk Res 2009 1.50
6 Polymorphisms in folate-related genes: impact on risk of adult acute lymphoblastic leukemia rather than pediatric in Han Chinese. Leuk Lymphoma 2011 1.46
7 Heat shock protein 90 inhibition results in altered downstream signaling of mutant KIT and exerts synergistic effects on Kasumi-1 cells when combining with histone deacetylase inhibitor. Leuk Res 2011 1.40
8 mRTVP-1, a novel p53 target gene with proapoptotic activities. Mol Cell Biol 2002 1.27
9 The expression of iASPP in acute leukemias. Leuk Res 2005 1.16
10 The FANCG Fanconi anemia protein interacts with CYP2E1: possible role in protection against oxidative DNA damage. Carcinogenesis 2002 1.16
11 Hierarchical, multilayered cell walls reinforced by recycled silk cocoons enhance the structural integrity of honeybee combs. Proc Natl Acad Sci U S A 2010 1.15
12 Adenoviral vector-mediated mRTVP-1 gene therapy for prostate cancer. Hum Gene Ther 2003 1.08
13 Analysis of FLT3 internal tandem duplication and D835 mutations in Chinese acute leukemia patients. Leuk Res 2005 1.07
14 Expression and role of DJ-1 in leukemia. Biochem Biophys Res Commun 2008 0.96
15 Long-term follow-up of clonal evolutions in 802 aplastic anemia patients: a single-center experience. Ann Hematol 2011 0.93
16 Caveolin-1-LRP6 signaling module stimulates aerobic glycolysis in prostate cancer. Cancer Res 2013 0.91
17 Icaritin induces AML cell apoptosis via the MAPK/ERK and PI3K/AKT signal pathways. Int J Hematol 2013 0.91
18 Some novel features of IDH1-mutated acute myeloid leukemia revealed in Chinese patients. Leuk Res 2011 0.91
19 High-dose cyclophosphamide compared with antithymocyte globulin for treatment of acquired severe aplastic anemia. Exp Hematol 2013 0.91
20 Macrophages transduced with an adenoviral vector expressing interleukin 12 suppress tumor growth and metastasis in a preclinical metastatic prostate cancer model. Cancer Res 2003 0.91
21 Enrichment of N-Cadherin and Tie2-bearing CD34+/CD38-/CD123+ leukemic stem cells by chemotherapy-resistance. Cancer Lett 2010 0.87
22 Expression of sorcin predicts poor outcome in acute myeloid leukemia. Leuk Res 2003 0.87
23 Overexpression of Rac1 in leukemia patients and its role in leukemia cell migration and growth. Biochem Biophys Res Commun 2009 0.86
24 Glioma pathogenesis-related protein 1 induces prostate cancer cell death through Hsc70-mediated suppression of AURKA and TPX2. Mol Oncol 2012 0.86
25 Therapeutic experience of adult acute myeloid leukemia in a single institution of China and its relationship with chromosome karyotype. Leuk Lymphoma 2008 0.85
26 The Hsp90 inhibitor 17-allylamide-17-demethoxygeldanamycin induces apoptosis and differentiation of Kasumi-1 harboring the Asn822Lys KIT mutation and down-regulates KIT protein level. Leuk Res 2005 0.84
27 Systemic GLIPR1-ΔTM protein as a novel therapeutic approach for prostate cancer. Int J Cancer 2013 0.84
28 AML1-ETO decreases ETO-2 (MTG16) interactions with nuclear receptor corepressor, an effect that impairs granulocyte differentiation. Cancer Res 2004 0.83
29 Nilotinib for imatinib-resistant or -intolerant chronic myeloid leukemia in chronic phase, accelerated phase, or blast crisis: a single- and multiple-dose, open-label pharmacokinetic study in Chinese patients. Clin Ther 2009 0.83
30 Clinical characteristics and outcomes of mixed phenotype acute leukemia with Philadelphia chromosome positive and/or bcr-abl positive in adult. Int J Hematol 2011 0.83
31 Identification of novel inhibitors of BCR-ABL tyrosine kinase via virtual screening. Bioorg Med Chem Lett 2003 0.82
32 Activation of Rac1 GTPase promotes leukemia cell chemotherapy resistance, quiescence and niche interaction. Mol Oncol 2013 0.81
33 Monitoring the AML1/ETO fusion transcript to predict outcome in childhood acute myeloid leukemia. Pediatr Blood Cancer 2014 0.81
34 Ph-negative acute lymphocytic leukemia occurring after interferon therapy for Ph-positive chronic myelocytic leukemia. Leuk Res 2003 0.81
35 Inhibition of sorcin reverses multidrug resistance of K562/A02 cells and MCF-7/A02 cells via regulating apoptosis-related proteins. Cancer Chemother Pharmacol 2013 0.81
36 Intensive induction chemotherapy with regimen containing intermediate dose cytarabine in the treatment of de novo acute myeloid leukemia. Am J Hematol 2009 0.81
37 Expression of pig7 gene in acute leukemia and its potential to modulate the chemosensitivity of leukemic cells. Leuk Res 2009 0.80
38 Synthesis of a dual functional anti-MDR tumor agent PH II-7 with elucidations of anti-tumor effects and mechanisms. PLoS One 2012 0.80
39 Mutation analysis of isocitrate dehydrogenase in acute lymphoblastic leukemia. Genet Test Mol Biomarkers 2012 0.80
40 Metformin induces differentiation in acute promyelocytic leukemia by activating the MEK/ERK signaling pathway. Biochem Biophys Res Commun 2012 0.79
41 Low-expression of E-cadherin in leukaemia cells causes loss of homophilic adhesion and promotes cell growth. Cell Biol Int 2011 0.79
42 Identification of a novel isoform of iASPP and its interaction with p53. J Mol Biol 2007 0.79
43 AML1-ETO interacts with Sp1 and antagonizes Sp1 transactivity through RUNT domain. FEBS Lett 2008 0.79
44 RAD51 and XRCC3 polymorphisms: impact on the risk and treatment outcomes of de novo inv(16) or t(16;16)/CBFβ-MYH11(+) acute myeloid leukemia. Leuk Res 2011 0.79
45 AML1/RUNX1 fusion gene and t(5;21)(q13;q22) in a case of chronic myelomonocytic leukemia with progressive thrombocytopenia and monocytosis. Cancer Genet Cytogenet 2004 0.79
46 Overexpression of Midkine promotes the viability of BA/F3 cells. Biochem Biophys Res Commun 2009 0.79
47 Additional chromosomal abnormalities and their prognostic significance in adult Philadelphia-positive acute lymphoblastic leukemia: with or without imatinib in chemotherapy. Ann Hematol 2009 0.79
48 Further stratification of patients with multiple myeloma by International Staging System in combination with ratio of serum free κ to λ light chains. Leuk Lymphoma 2012 0.78
49 Clinical characteristics and outcomes of adults with Philadelphia chromosome positive and/or bcr-abl positive acute lymphoblastic leukemia: a single center study from China. Leuk Lymphoma 2010 0.78
50 Van der Waals interaction-tuned heat transfer in nanostructures. Nanoscale 2012 0.78
51 Quantification of PML/RARa transcript after induction predicts outcome in children with acute promyelocytic leukemia. Int J Hematol 2012 0.78
52 Clinical and laboratory studies of 17 patients with acute myeloid leukemia harboring t(7;11)(p15;p15) translocation. Leuk Res 2013 0.78
53 IGH gene involvement in two cases of acute lymphoblastic leukemia with t(14;14)(q11;q32) identified by sequential R-banding and fluorescence in situ hybridization. Cancer Genet Cytogenet 2004 0.77
54 Effect of G-rich oligonucleotides on the proliferation of leukemia cells and its relationship with p53 expression. Oligonucleotides 2011 0.77
55 Glutathione S-transferases (GSTT1 and GSTM1) genes polymorphisms and the treatment response and prognosis in Chinese patients with de novo acute myeloid leukemia. Leuk Res 2007 0.77
56 Reversal of Imatinib resistance in BCR-ABL-positive leukemia after inhibition of the Na+/H+ exchanger. Cancer Lett 2011 0.76
57 Expression and clinical implication of soluble resistance-associated calcium-binding protein gene and multi-drug resistance gene in leukemia. Zhonghua Zhong Liu Za Zhi 2002 0.76
58 Meta-analysis for the potential application of FLT3-TKD mutations as prognostic indicator in non-promyelocytic AML. Leuk Res 2011 0.76
59 A multicenter, open-label study of posaconazole oral suspension in the treatment of invasive fungal infections in patients refractory to or intolerant of first-line therapy. Future Microbiol 2012 0.76
60 A new caspase-8 isoform caspase-8s increased sensitivity to apoptosis in Jurkat cells. J Biomed Biotechnol 2010 0.75
61 Long-term follow-up of homoharringtonine plus all-trans retinoic acid-based induction and consolidation therapy in newly diagnosed acute promyelocytic leukemia. Int J Hematol 2015 0.75
62 [Determination of ETO interaction domain within nuclear receptor co-repressor]. Zhonghua Xue Ye Xue Za Zhi 2002 0.75
63 iASPPsv antagonizes apoptosis induced by chemotherapeutic agents in MCF-7 cells and mouse thymocytes. Biochem Biophys Res Commun 2012 0.75
64 Expression and clinical implications of the soluble drug resistance-related calcium-binding protein (sorcin) gene in leukemia patients. Zhonghua Xue Ye Xue Za Zhi 2002 0.75
65 [Analysis on the laboratory examination characteristics in 22 patients with acute megakaryoblastic leukemia]. Zhonghua Xue Ye Xue Za Zhi 2016 0.75
66 Clinical characteristics and treatment outcome of adult acute lymphoblastic leukemia with t(4;11)(q21;q23) using a modified hyper-CVAD regimen. Acta Haematol 2009 0.75
67 Monitoring of minimal residual disease in acute myeloid leukemia with t(8;21)(q22;q22). Int J Hematol 2013 0.75
68 [Modified pedicled cranial periosteum compound flap to reconstruct the defect of anterior cranial fossa complicated with cerebrospinal fluid leakage]. Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 2011 0.75
69 Heat transfer in heterogeneous nanostructures can be described by a simple chain model. Phys Chem Chem Phys 2014 0.75
70 Impact of risk stratification on the duration of caspofungin therapy for invasive fungal disease in acute leukemic patients. Future Microbiol 2015 0.75
71 Acute leukemia association with psoriasis: a report on 100 patients from a single center in China. Am J Hematol 2010 0.75